Toshie Saito1,2,3, Kazuya Miyagawa1,2,3, Shih-Yu Chen4,5, Rasa Tamosiuniene1,2,6, Lingli Wang1,2,3, Orr Sharpe6, Erik Samayoa7, Daisuke Harada6, Jan-Renier A J Moonen1,2,3, Aiqin Cao1,2,3, Pin-I Chen1,2,3, Jan K Hennigs1,2,3, Mingxia Gu1,2,3, Caiyun G Li1,2,3, Ryan D Leib, Dan Li1,2,3, Christopher M Adams, Patricia A Del Rosario1,6, Matthew Bill1,6, Francois Haddad2,6, Jose G Montoya6, William H Robinson6, Wendy J Fantl4,5,8, Garry P Nolan4,5, Roham T Zamanian1,2,6, Mark R Nicolls1,2,6, Charles Y Chiu7, Maria E Ariza9, Marlene Rabinovitch10,2,3. 1. Vera Moulton Wall Center for Pulmonary Vascular Disease (T.S., K.M., R.T., L.W., J.-R.A.J.M., A.C., P.-I.C., J.K.H., M.G., C.G.L., D.L., P.A.d.R., M.B., R.T.Z., M.R.N., M.R.). 2. Cardiovascular Institute (T.S., K.M., R.T., L.W., J.-R.A.J.M., A.C., P.-I.C., J.K.H., M.G., C.G.L., D.L., F.H., R.T.Z., M.R.N., M.R.). 3. Department of Pediatrics (T.S., K.M., L.W., J.-R.A.J.M., A.C., P.-I.C., J.K.H., M.G., C.G.L., D.L., M.R.). 4. Department of Microbiology and Immunology (S.-Y.C., W.J.F., G.P.N.). 5. Baxer Laboratory for Stem Cell Biology (S.-Y.C., W.J.F., G.P.N.). 6. Department of Medicine (R.T., O.S., D.H., P.A.d.R., M.B., F.H., J.G.M., W.H.R., R.T.Z., M.R.N.). 7. Stanford University School of Medicine, CA. Department of Laboratory Medicine and Medicine/Infectious Diseases (E.S., C.Y.C.), and Viral Diagnostics and Discovery Center University of California, San Francisco (E.S., C.Y.C.). 8. Vincent Coates Foundation Mass Spectrometry Laboratory (R.D.L., C.M.A.), and Department of Obstetrics and Gynecology (W.J.F.). 9. Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, OH (M.E.A.). 10. Vera Moulton Wall Center for Pulmonary Vascular Disease (T.S., K.M., R.T., L.W., J.-R.A.J.M., A.C., P.-I.C., J.K.H., M.G., C.G.L., D.L., P.A.d.R., M.B., R.T.Z., M.R.N., M.R.), marlener@stanford.edu.
Abstract
BACKGROUND: Immune dysregulation has been linked to occlusive vascular remodeling in pulmonary arterial hypertension (PAH) that is hereditary, idiopathic, or associated with other conditions. Circulating autoantibodies, lung perivascular lymphoid tissue, and elevated cytokines have been related to PAH pathogenesis but without a clear understanding of how these abnormalities are initiated, perpetuated, and connected in the progression of disease. We therefore set out to identify specific target antigens in PAH lung immune complexes as a starting point toward resolving these issues to better inform future application of immunomodulatory therapies. METHODS: Lung immune complexes were isolated and PAH target antigens were identified by liquid chromatography tandem mass spectrometry, confirmed by enzyme-linked immunosorbent assay, and localized by confocal microscopy. One PAH antigen linked to immunity and inflammation was pursued and a link to PAH pathophysiology was investigated by next-generation sequencing, functional studies in cultured monocytes and endothelial cells, and hemodynamic and lung studies in a rat. RESULTS: SAM domain and HD domain-containing protein 1 (SAMHD1), an innate immune factor that suppresses HIV replication, was identified and confirmed as highly expressed in immune complexes from 16 hereditary and idiopathic PAH versus 12 control lungs. Elevated SAMHD1 was localized to endothelial cells, perivascular dendritic cells, and macrophages, and SAMHD1 antibodies were prevalent in tertiary lymphoid tissue. An unbiased screen using metagenomic sequencing related SAMHD1 to increased expression of human endogenous retrovirus K (HERV-K) in PAH versus control lungs (n=4). HERV-K envelope and deoxyuridine triphosphate nucleotidohydrolase mRNAs were elevated in PAH versus control lungs (n=10), and proteins were localized to macrophages. HERV-K deoxyuridine triphosphate nucleotidohydrolase induced SAMHD1 and proinflammatory cytokines (eg, interleukin 6, interleukin 1β, and tumor necrosis factor α) in circulating monocytes, pulmonary arterial endothelial cells, and also activated B cells. Vulnerability of pulmonary arterial endothelial cells (PAEC) to apoptosis was increased by HERV-K deoxyuridine triphosphate nucleotidohydrolase in an interleukin 6-independent manner. Furthermore, 3 weekly injections of HERV-K deoxyuridine triphosphate nucleotidohydrolase induced hemodynamic and vascular changes of pulmonary hypertension in rats (n=8) and elevated interleukin 6. CONCLUSIONS: Our study reveals that upregulation of the endogenous retrovirus HERV-K could both initiate and sustain activation of the immune system and cause vascular changes associated with PAH.
BACKGROUND: Immune dysregulation has been linked to occlusive vascular remodeling in pulmonary arterial hypertension (PAH) that is hereditary, idiopathic, or associated with other conditions. Circulating autoantibodies, lung perivascular lymphoid tissue, and elevated cytokines have been related to PAH pathogenesis but without a clear understanding of how these abnormalities are initiated, perpetuated, and connected in the progression of disease. We therefore set out to identify specific target antigens in PAH lung immune complexes as a starting point toward resolving these issues to better inform future application of immunomodulatory therapies. METHODS: Lung immune complexes were isolated and PAH target antigens were identified by liquid chromatography tandem mass spectrometry, confirmed by enzyme-linked immunosorbent assay, and localized by confocal microscopy. One PAH antigen linked to immunity and inflammation was pursued and a link to PAH pathophysiology was investigated by next-generation sequencing, functional studies in cultured monocytes and endothelial cells, and hemodynamic and lung studies in a rat. RESULTS: SAM domain and HD domain-containing protein 1 (SAMHD1), an innate immune factor that suppresses HIV replication, was identified and confirmed as highly expressed in immune complexes from 16 hereditary and idiopathic PAH versus 12 control lungs. Elevated SAMHD1 was localized to endothelial cells, perivascular dendritic cells, and macrophages, and SAMHD1 antibodies were prevalent in tertiary lymphoid tissue. An unbiased screen using metagenomic sequencing related SAMHD1 to increased expression of human endogenous retrovirus K (HERV-K) in PAH versus control lungs (n=4). HERV-K envelope and deoxyuridine triphosphate nucleotidohydrolase mRNAs were elevated in PAH versus control lungs (n=10), and proteins were localized to macrophages. HERV-K deoxyuridine triphosphate nucleotidohydrolase induced SAMHD1 and proinflammatory cytokines (eg, interleukin 6, interleukin 1β, and tumor necrosis factor α) in circulating monocytes, pulmonary arterial endothelial cells, and also activated B cells. Vulnerability of pulmonary arterial endothelial cells (PAEC) to apoptosis was increased by HERV-K deoxyuridine triphosphate nucleotidohydrolase in an interleukin 6-independent manner. Furthermore, 3 weekly injections of HERV-K deoxyuridine triphosphate nucleotidohydrolase induced hemodynamic and vascular changes of pulmonary hypertension in rats (n=8) and elevated interleukin 6. CONCLUSIONS: Our study reveals that upregulation of the endogenous retrovirus HERV-K could both initiate and sustain activation of the immune system and cause vascular changes associated with PAH.
Keywords:
SAM domain and HD domain-containing protein 1 (SAMHD1); deoxyuridine triphosphate nucleotidohydrolase (dUTPase); human endogenous retrovirus K (HERV-K); pulmonary arterial hypertension (PAH); tertiary lymphoid tissue
Authors: Séverine Valmary; Peter Dorfmüller; David Montani; Marc Humbert; Pierre Brousset; Bruno Degano Journal: Chest Date: 2010-11-04 Impact factor: 9.410
Authors: David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb Journal: Nature Date: 2011-11-06 Impact factor: 49.962
Authors: Stefanie Kretschmer; Christine Wolf; Nadja König; Wolfgang Staroske; Jochen Guck; Martin Häusler; Hella Luksch; Laura A Nguyen; Baek Kim; Dimitra Alexopoulou; Andreas Dahl; Alexander Rapp; M Cristina Cardoso; Anna Shevchenko; Min Ae Lee-Kirsch Journal: Ann Rheum Dis Date: 2014-01-20 Impact factor: 19.103
Authors: Michał J Kowalczyk; Aleksandra Dańczak-Pazdrowska; Beata Szramka-Pawlak; Ryszard Zaba; Wojciech Silny; Agnieszka Osmola-Mańkowska Journal: Arch Med Sci Date: 2012-10-08 Impact factor: 3.318
Authors: Evan L Brittain; Thennapan Thennapan; Bradley A Maron; Stephen Y Chan; Eric D Austin; Edda Spiekerkoetter; Harm J Bogaard; Christophe Guignabert; Roxane Paulin; Roberto F Machado; Paul B Yu Journal: Am J Respir Crit Care Med Date: 2018-07-01 Impact factor: 21.405
Authors: Salina Gairhe; Keytam S Awad; Edward J Dougherty; Gabriela A Ferreyra; Shuibang Wang; Zu-Xi Yu; Kazuyo Takeda; Cumhur Y Demirkale; Parizad Torabi-Parizi; Eric D Austin; Jason M Elinoff; Robert L Danner Journal: Proc Natl Acad Sci U S A Date: 2021-03-16 Impact factor: 11.205
Authors: Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler Journal: Pulm Circ Date: 2019-11-20 Impact factor: 3.017
Authors: Kyle A Batton; Christopher O Austin; Katelyn A Bruno; Charles D Burger; Brian P Shapiro; DeLisa Fairweather Journal: Biol Sex Differ Date: 2018-04-18 Impact factor: 5.027